CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 22 enrolled
Drug / intervention
Tele-Navi LCSbehavioral
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT05021133
NCT05021133N/ACompleted
CompareCT.gov

Tele-Navigation of Lung Cancer Screening

University of Massachusetts, Worcester·interventional·Posted Aug 25, 2021·Updated Jan 8, 2026

In Brief

A clinical study evaluating Tele-Navi LCS for Lung Cancer. Completed, enrolled 22 participants across 1 site.

Detailed Summary

Adherence to annual follow up is critical to achieving mortality benefits and optimizing cost-effectiveness of lung cancer screening (LCS). However, adherence to LCS follow-up in the real world is suboptimal. Using telehealth, the investigators will co-create Tele-Navigation of Lung Cancer Screening with patients and LCS stakeholders as an intervention to promote adherence of follow-up LCS. The investigators will then implement the Tele-Navi LCS intervention to a pilot sample of patients and evaluate its feasibility in the primary care setting. The investigators will measure the number of patient participants who completed Tele-Navi LCS and follow-up LCS within 180 days from Tele-Navi LCS.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsLung Cancer
CountriesUnited States
CollaboratorsWake Forest University Health Sciences, National Institutes of Health (NIH), National Cancer Institute (NCI)

Timeline

N/ACompletedFinished
20222023202420252026
First PostedAug 25, 2021
Enrollment StartJun 5, 2023
Primary CompletionAug 11, 2023
Study CompletionDec 12, 2025
TodayJul 2, 2026
Enrollment to primary: 2 monthsPosted 4.9 years ago

Interventions

Tele-Navi LCSbehavioral

Tele-Navi of LCS includes: telehealth coaching from a Tele-Navigator for patients undergoing LCS using a video or telephone call